University of Pennsylvania
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1740-11-14
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.upenn.edu
Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer
Phase 2
Terminated
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Drug: ItacitinibBiological: Pembrolizumab
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 23
- Registration Number
- NCT03425006
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
Phase 1
Active, not recruiting
- Conditions
- Bacterial Infections
- Interventions
- Drug: 11C-Trimethoprim
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 30
- Registration Number
- NCT03424525
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Mobile Health (mHealth) Nutrition Intervention for Children With Autism Spectrum Disorder
Not Applicable
Completed
- Conditions
- Diet Modification
- Interventions
- Device: Mobile Health Intervention
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 38
- Registration Number
- NCT03424811
- Locations
- 🇺🇸
Center for Weight and Eating Disorders, Philadelphia, Pennsylvania, United States
SMaRT Blood: Single-unit Versus Multiple-unit Packed Red Blood Cell Transfusion in Non-acute Postpartum Anemia
Not Applicable
Completed
- Conditions
- Postpartum Anemia Nos
- Interventions
- Biological: Blood Transfusion
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 66
- Registration Number
- NCT03419780
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Mobile Devices as Educational Skin History Tools
Not Applicable
Completed
- Conditions
- Skin Cancer
- Interventions
- Other: Mobile app
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 70
- Registration Number
- NCT03419637
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Cerebrovascular Reactivity in American Football Players
Phase 1
Terminated
- Conditions
- Mild Traumatic Brain InjuryPost-Concussion SyndromeTraumatic Brain Injury
- Interventions
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 7
- Registration Number
- NCT03417492
- Locations
- 🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
Remote Monitoring and Social Support for Hypertension Management
Not Applicable
Completed
- Conditions
- Hypertension
- Interventions
- Behavioral: Remote MonitoringBehavioral: Remote Monitoring + Social Support
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 250
- Registration Number
- NCT03416283
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Journey of Patients With Vasculitis From First Symptom to Diagnosis
Completed
- Conditions
- VasculitisSystemic VasculitisCryoglobulinemic VasculitisTemporal ArteritisGiant Cell ArteritisIgA VasculitisCNS VasculitisEosinophilic Granulomatous VasculitisWegener GranulomatosisHenoch Schonlein Purpura
- Interventions
- Other: Online Questionnaire
- First Posted Date
- 2018-01-25
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 456
- Registration Number
- NCT03410290
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
Air Pollution, Asthma and Circadian Clocks
Active, not recruiting
- Conditions
- AsthmaHealthy
- Interventions
- Other: Observational
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 20
- Registration Number
- NCT03406351
- Locations
- 🇺🇸
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
Phase 1
Completed
- Conditions
- Pancreatic Adenocarcinoma
- Interventions
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 104
- Registration Number
- NCT03404960
- Locations
- 🇺🇸
University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath